Viridos
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $100M
Investors
- 6
About Viridos
Synthetic Genomics, Inc.Founded in 2005 in the United States, Synthetic Genomics, Inc. focuses on creating low-carbon intensity biofuels.Viridos specializes in the development of low-carbon intensity biofuels derived from engineered microalgae, addressing critical challenges in decarbonizing industries such as aviation, commercial trucking, and maritime shipping. Their core offerings include proprietary algal strains optimized for high oil production, capable of flourishing in saltwater and climate conditions that do not compete with agricultural resources. The company operates various production sites where these microalgae are cultivated sustainably. Viridos targets markets globally, particularly focusing on North America and regions requiring renewable fuel alternatives to fossil fuels.The revenue structure of Viridos is derived from collaborations and partnerships within the biofuel industry, particularly with clients in heavy transportation sectors. These transactions typically occur through B2B arrangements where Viridos supplies its advanced algal biofuels to commercial entities such as airlines, freight companies, and shipping firms. By offering high-quality, sustainable fuel alternatives, the company bolsters its client relationships and facilitates long-term contracts. Specific pricing models reflect a commitment to competitive rates in the renewable energy market, with financial arrangements structured around volume commitments and supply agreements. The company aims to expand its product offerings and enhance its market presence, particularly in North America and other regions seeking renewable fuel alternatives.
Who invested in Viridos
6 investors across 5 rounds
See all investors in Viridos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Viridos
Who invested in Viridos?
Viridos has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Viridos raised?
Viridos has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Viridos last raise money?
Viridos's most recent round on record is a Series A, in Mar 2023.
What does Viridos do?
Viridos is a biotechnology company.
Where is Viridos headquartered?
Viridos is headquartered in US.
Which VCs invest in companies like Viridos?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Viridos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Viridos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.